We are developing organ-on-a-chip technology to enable the replication of patient specific physiological functions for the purpose of diagnostics and drug development. Emulating the patient`s cancer on a microchip, multiple treatment strategies can be tested and evaluated prior to applying them. Our technology will provide unprecedented advantage in the personalized assessment of cancer immunotherapy efficacy.
